These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9114160)

  • 1. Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine.
    Berg SW; Mitchell BS; Hanson RK; Olafson RP; Williams RP; Tueller JE; Burton RJ; Novak DM; Tsai TF; Wignall FS
    Clin Infect Dis; 1997 Feb; 24(2):265-6. PubMed ID: 9114160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further experience with Japanese encephalitis vaccine.
    Sanchez JL; Hoke CH; McCown J; DeFraites RF; Takafuji ET; Diniega BM; Pang LW
    Lancet; 1990 Apr; 335(8695):972-3. PubMed ID: 1970043
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines.
    Sakaguchi M; Yoshida M; Kuroda W; Harayama O; Matsunaga Y; Inouye S
    Vaccine; 1997 Feb; 15(2):121-2. PubMed ID: 9066026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic allergic reactions to Japanese encephalitis vaccines.
    Nazareth B; Levin J; Johnson H; Begg N
    Vaccine; 1994 May; 12(7):666. PubMed ID: 8085387
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection against Japanese encephalitis by inactivated vaccines.
    Hoke CH; Nisalak A; Sangawhipa N; Jatanasen S; Laorakapongse T; Innis BL; Kotchasenee S; Gingrich JB; Latendresse J; Fukai K
    N Engl J Med; 1988 Sep; 319(10):608-14. PubMed ID: 2842677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions to Japanese encephalitis vaccine.
    Ruff TA; Eisen D; Fuller A; Kass R
    Lancet; 1991 Oct; 338(8771):881-2. PubMed ID: 1681228
    [No Abstract]   [Full Text] [Related]  

  • 8. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines.
    Nimmannitya S; Hutamai S; Kalayanarooj S; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):689-93. PubMed ID: 9139377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.
    Gambel JM; DeFraites R; Hoke C; Brown A; Sanchez J; Karabatsos N; Tsai T; Meschievitz C
    J Infect Dis; 1995 Apr; 171(4):1074. PubMed ID: 7706798
    [No Abstract]   [Full Text] [Related]  

  • 10. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic mucocutaneous reactions to Japanese encephalitis vaccine.
    Plesner AM; Rønne T
    Vaccine; 1997 Aug; 15(11):1239-43. PubMed ID: 9286050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis to Japanese encephalitis vaccine.
    Sakaguchi M; Nakashima K; Takahashi H; Nakayama T; Fujita H; Inouye S
    Allergy; 2001 Aug; 56(8):804-5. PubMed ID: 11488694
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group.
    Takahashi H; Pool V; Tsai TF; Chen RT
    Vaccine; 2000 Jul; 18(26):2963-9. PubMed ID: 10825597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Advisory Committee on Immunization (NACI). Statement on Japanese encephalitis vaccine.
    Can Commun Dis Rep; 1993 Oct; 19(19):160-4. PubMed ID: 8251988
    [No Abstract]   [Full Text] [Related]  

  • 15. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
    Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants.
    Poland JD; Cropp CB; Craven RB; Monath TP
    J Infect Dis; 1990 May; 161(5):878-82. PubMed ID: 2324539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observations on the reactions following vaccination of the inactivated Japanese encephalitis virus vaccine from tissue culture (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Mar; 15(2):98-100. PubMed ID: 7307821
    [No Abstract]   [Full Text] [Related]  

  • 18. Intradermal boosting of Japanese encephalitis vaccination.
    Kitchener S; Baade L; Brennan L; Nasveld P
    J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine].
    Yuan CD
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):210-4. PubMed ID: 2805047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pregnancy on protection of mice immunized by Japanese encephalitis virus & its experimental inactivated vaccine.
    Soni GR
    Indian J Med Res; 1994 Aug; 100():57-8. PubMed ID: 7927555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.